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Abstract. Nanotechnology represents an area of particular promise and significant
opportunity across multiple scientific disciplines. Ongoing nanotechnology research ranges
from the characterization of nanoparticles and nanomaterials to the analysis and processing
of experimental data seeking correlations between nanoparticles and their functionalities
and side effects. Due to their special properties, nanoparticles are suitable for cellular-level
diagnostics and therapy, offering numerous applications in medicine, e.g. development of
biomedical devices, tissue repair, drug delivery systems and biosensors. In nanomedicine,
recent studies are producing large amounts of structural and property data, highlighting the
role for computational approaches in information management. While in vitro and in vivo
assays are expensive, the cost of computing is falling. Furthermore, improvements in the
accuracy of computational methods (e.g. data mining, knowledge discovery, modeling and
simulation) have enabled effective tools to automate the extraction, management and storage
of these vast data volumes. Since this information is widely distributed, one major issue is
how to locate and access data where it resides (which also poses data-sharing limitations).
The novel discipline of nanoinformatics addresses the information challenges related to
nanotechnology research. In this paper, we summarize the needs and challenges in the field
and present an overview of extant initiatives and efforts.
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1. Introduction
Over the last 20 years, nanotechnology has pushed back the frontiers of science and has especially
revolutionized the field of medicine (Duncan and Gaspar 2011). This novel scientific field deals with materials
at the nano-dimension (macromolecules that range in size from 1 to 100 nm), offering breakthroughs in a wide
range of scientific areas, such as physics, chemistry, microbiology and materials science, but also posing many
challenges (Lemley 2005).
At the nanoscale, physical, chemical and functional properties differ from those at the cell, tissue or organ
level (McNeil 2011). Unique characteristics emerge from nanoparticles, based on their size—they are small
enough to interact with receptors with high specificity and effectiveness and large enough to carry drugs at the
molecular level—and also on their quantum properties: density, stability or unexpected optical properties such
as high absorption of solar radiation (Scholes and Rumbles 2006) or superparamagnetism (Sato et al 2011),
for instance. All this represents a dramatic turnaround from a few years ago for the scientific community.
In medicine, worldwide efforts to foster these novel technologies promises to bring us new insights into
the development of biomarkers and personalized treatments, but also raises concerns about inefficacy in the
management and analysis of all of this new information to address potential hazards and risks. In this sense,
society’s perception of nanotechnology requires strong consideration since it could influence industry oversight
of future advancements in the area.
One current issue regarding nanoparticles is potential toxicity, a field that is still obscure to researchers.
It is unclear how and what toxicity some nanoparticles have and there is a lack of extensive regulation for
new products derived from them. What may be harmless at the macro or chemical level may have different
effects in the body than the nanoparticle form. Possibly the largest time- and money-related costs involved in
developing nanomaterials may not be in making them work, but in determining their side effects and biological
impacts.
Computational methods and tools offer novel paradigms to materials discovery and design, improving
properties prediction or material selection capabilities that could increase product performance and reduce time
from drug discovery to marketing. The novel discipline of nanoinformatics deals with all of these information
challenges related to nanotechnology research and, specifically, with nanomedicine (Maojo et al 2012a).
Several nanoinformatics initiatives are currently identifying data gaps and research priorities in the area and
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developing collaborative nanoinformatics environments where research institutions can publish descriptions
of their data sources and make them publicly available over the Internet.
In this paper, we present an overview of the needs and challenges in nanoinformatics, as well as the extant
initiatives and international efforts in the field. All these initiatives are fostering scientific advancement and
knowledge dissemination in the nanomedical area and closing the gaps between basic research and clinical
applications (de la Iglesia et al 2011).
1.1. Applications of nanoparticles in medicine
Groundbreaking advances in nanoscience continue to provide incremental insights into medicine. Among
numerous potential applications, such as biosensors, biological carriers for drug delivery or structures for tissue
repair, we illustrate in this section some examples of the more innovative research in the field of nanomedicine.
We can differentiate two contexts in nanotechnology applications: diagnostics (based on molecular biosensing)
and therapeutics, which follow tailored strategies.
As biomarkers and imaging contrast agents, nanoparticles can be decorated with specific diagnostic
agents targeted to specific receptors (Maila¨nder and Landfester 2009), which allows monitoring of their
distribution (Haun et al 2011). This property has many diagnostic biosensing applications (Yeri and Gao 2011).
The large surface area of nanomaterials, chemically functionalized with targeting ligands, provides excellent
levels of sensitivity for the detection of molecular targets, such as DNA, proteins, pathogens, tumor cells or
enzymes (Kumbar et al 2008). For instance, scientists at the Northwestern University Feinberg School of
Medicine have developed a bio-barcode assay (Thaxton et al 2009) for detecting prostate-specific antigen
based on the use of gold nanoparticles and have recently defined nanocombinatorics (Giam et al 2012),
a new lithography technique that generates nanoscale biological patterns . In the NanoSystems Biology Cancer
Center at the California Institute of Technology, researchers have developed a nano-based, integrated platform
with two different applications: cell sorting and multiplex detection of DNA and proteins (Bailey et al 2007).
Photoacoustic molecular imaging is another potential application of nanoparticles as molecular markers. It
consists of marking biological targets with acoustic detectors, such as carbon nanotubes and gold nanoparticles.
This promising technique has been successfully applied in mice by the Molecular Imaging Program at Stanford
for multimodal brain tumor imaging (Kircher et al 2012) and for the diagnosis of retinal diseases (de la Zerda
et al 2012).
As delivery systems, nanoparticles are suitable for systematically releasing drugs to a specific target
(cell or tissue), increasing their efficiency and improving the characterization of the treatment response.
Nanocarriers can be seen as sophisticated mechanisms by which nano-sized objects can be transported
through the body to target specific cells and penetrate cellular and nuclear membranes. Advanced design
of nanomaterials has demonstrated that engineered nanoparticles can evade immune detection, facilitating
the targeted delivery of a specific drug. Nanoparticles hide their payloads, protecting drugs from several
defense mechanisms and biological barriers, such as particle disposal by phagocytic cells or renal plasma
clearance (Zuckerman et al 2012). Nanoparticles can also be used for gene delivery (Jin et al 2009), leading to
deactivation of genes related to a specific illness (e.g. cancer). The nanoparticle preserves its genetic payload
from degrading enzymes and the immune system and carries it into the target cells, as well. In addition,
advances in nanotechnology are being applied to in vitro regenerative medicine: tissue regeneration (Veetil
and Ye 2009), cardiovascular implants (Ghanbari et al 2011, de Mel et al 2012), cell therapy (Pera´n et al
2012), wound healing and delivery of exogenous growth factors (Koria 2012) are examples.
With regards to cancer research—one of the main areas where nanotechnology discoveries are being
applied—biological mechanisms are complex and drug interactions offer very different results between
in vitro and in vivo assays. However, with the use of nanoparticles, diagnostics and therapeutics could be
greatly improved for certain types of tumors, such as those tumors currently treated with toxic drugs—i.e. lung
(Upadhyay et al 2012) or breast cancer (Xin et al 2012)—or gene therapy—ovarian (Fathabadi et al 2012) and
brain cancer (Liu et al 2012). For instance, researchers at the University of Melbourne (Australia) are using
certain engineered nanostructures (polymers, micelles and polymersomes) as carriers to deliver drugs that
target cancer cells causing minimal biological side effects (Kamphuis et al 2010, Shimoni et al 2012). With the
same objective, the continuous efforts of the National Cancer Institute (NCI) to apply nanotechnology-based
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advances to early diagnosis and effective therapy against cancer (Service 2005, 2010, Ptak et al 2010, Shukla
et al 2011) is also worthy of mention. There are other remarkable examples of innovative nanomedical
research. At the University of North Carolina, researchers are conducting experiments that use the novel
PRINT technique (Perry et al 2011) for nanoparticle replication and mimicry (Parrott et al 2012, Wang et al
2012), obtaining new particles that can be tuned with controlled properties, e.g. elasticity, size or shape. Such
advances could be applied to the development of nanoparticles for use in the emerging area of theranostics
(Kelkar and Reineke 2011, Perry et al 2011, Kiessling et al 2012), a new paradigm that combines diagnostics
and therapy for individual patients in one step.
However, there is an urgent need to shorten the timeline between the acquisition of fundamental
knowledge about nanomaterials, the publication of related studies and assays in scientific media and their
clinical application. Social concerns about nanoparticles toxicity or nanotoxicity (the potential negative health
impact of exposure to nanomaterials) could be a barrier for the agile and efficient transfer of nanotechnology
from the bench to the bedside (Bellare 2011). This could be addressed by supporting responsible
nanotechnology development, providing high-quality information through a better exchange system and
sharing available toxicity and physico-chemical data to efficiently determine the association between exposure
to nanomaterials and side effects. In both the diagnostic and treatment contexts, pharmacokinetic behavior
and potential risks pose by nanoparticle-based drugs should be studied in-depth, considering both genotypic
and phenotypic studies. Currently, in most cases, early clinical trials on nanoparticles are not revealing new
toxic effects from the nanoparticle itself or its components. Therefore, it would be necessary to differentiate
between the toxicity of the container and that of its payload (i.e. surface versus core), which are cornerstones
in determining and monitoring the efficacy and adverse health effects of new nanomaterials. Indeed, in the case
of nanomedicines, the development and approval of new drugs does not need to take so long and clinical trials
are not necessarily vital in some cases, particularly when considering that nanomaterials are generally derived
from drugs previously authorized by the US Food and Drug Administration (FDA) (Etheridge et al 2013) or the
European Medicines Agency (Karalis and Macheras 2012). There are many drugs already approved or under
commercial use, such as those for therapy against cancer—Daunoxome R© (Petre and Dittmer 2007), Doxil R©
(Pearce et al 2012) and Caelyx R© (Li et al 2012), among others—, bone substitutes such as CarriGen R©3, dental
composites such as FilTek R© (Moosavi et al 2012), or platforms as the Verigene R© System (Buxton 2009), which
is extensively used in hospitals for diagnostic purposes. Considering the myriad of new and increasingly rapid
results generated by nanomedical research nowadays, it is obvious that the development of new tools for
managing all this information has become crucial for advancing the field.
2. Information in nanomedicine
Information delivery channels are rapidly evolving, generating an increasing need to manage available data and
resources. Specifically, discovery and design of new materials (Bikiaris 2007, Huh and Kwon 2011, Majzoub
and Ro¨nnebro 2012, Mentovich et al 2012) and recent advances in personalized medicine (Jain 2011) raise
new challenges in the analysis and integration of the massive heterogeneous data generated by nanomedical
research.
Unfortunately, researchers are facing many difficulties in their daily tasks related to information retrieval
and management in nanomedicine. The number of sources is huge, and is increasing every day, but the available
information is not always what is required while, in other cases, the data are not comprehensive or the quality
is not sufficiently high. In addition, professionals currently working on nanotechnology have different roles
and professional profiles, such as researchers, program managers, policy makers, infrastructure providers,
clinicians, students and workers. Thus, the type of information to be managed is very complete and of broad
scope, but also heterogeneous with regards to format and content. Information about researchers, research
programs, tools, nanomaterial data and current projects is distributed among numerous sources, leading to a
considerable disconnect between resources and users currently performing clinical, environmental, medical
and basic research. Thus, how to manage nanoinformation is still the open question for computer scientists.
3 CarriGen R©, porous bone substitute material composed of a proprietary nanocrystalline calcium phosphate formulation that mimics
the crystalline mineral structure of human bone. ETEX products. https://secure.etexcorp.com/products overview.html.
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Figure 1. Top terms that appear in research publications related to nanomedicine.
Figure 1 shows the top terms appearing in nanomedical research publications, demonstrating the variety of
concepts (from tissues to cells to particles) embraced by nanomedicine.
Over the last year, there has been a proliferation of computational resources related to the area of
nanotechnology and, specifically, nanomedicine. As proposed elsewhere (Baker et al 2009, Maojo et al 2010,
2012b), nanoinformatics deals with how to extract useful information from all available data relevant to
nanotechnology. Because this novel discipline is in its early stages, research on nanoinformatics currently faces
many challenges: (i) the definition of semantics in the field; (ii) the standardization and integration of data;
(iii) the interoperability of resources; (iv) the lack of consistent annotations; and (iv) the necessary integration
of data analysis tools with databases. Building cooperation among these areas may facilitate the development
of useful and effective nanoinformatics methods and tools.
2.1. From data to knowledge
The inference of knowledge from raw data sets involves several steps: (i) data collection; (ii) data analysis
and annotation; (iii) information extraction; and, finally; and (iv) data validation by experts in the field. With
regards to data collection, we currently face serious restrictions for accessing nanomaterial data, such as the
unwillingness to share experiments and results or the existence of proprietary data that is not publicly available.
In addition, some of the experimental results reported in the scientific literature contain numerical errors or are
not properly described—in terms of protocols, experiment parameters or techniques—, so it is not possible to
reproduce the experiment. Therefore, in order to extract high-quality information from raw data sets, a huge
effort is needed to validate and curate existing repositories, deleting invalid and redundant data.
Knowledge inference also involves classifying and ranking information into categories and requires the
definition of a specific semantic domain, based on standard terminologies and vocabularies. Specifically,
knowledge discovery in nanomedicine should be driven by two means: (i) biological and clinical problems
and (ii) research data and models. Biological and clinical problems raise the target questions and challenges
to be addressed: what tasks need to be supported and which resources—data and services—are needed. With
regards to the second point, we find data modeling to be an issue: semantics requires a solid context to be
defined in order to achieve data consistency between research results and predictive models.
Informatics tools aim to define this context by providing different techniques and methodologies—
models, taxonomies and ontologies—to ensure data quality and harmonization and to interpret the meaning of
data, turning it into usable information and knowledge. Additionally, computational methods to store, organize
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and manage the huge volumes of digital data generated during research on nanomedicine could be used to:
(i) integrate structural and functional characterization research data with multiple types of ‘nano’ information
(with clinical trial data, for instance); and (ii) find, through the development of data analysis methods, potential
associations between the size, structure, composition and physical and chemical properties of nanoparticles,
as well as the extant correlations between in vitro and in vivo assays.
2.2. Information standards
Information standards are the basis of any scientific discipline. Using a common formalism to represent the
elements within a domain guarantees the creation of dynamic, interoperable information systems that share
data models linked to standard terminologies. Due to the wide range and heterogeneity of fields contributing
to nanotechnology, global consensus in semantics—nomenclatures, code sets, descriptions, classifications and
specifications of nanomaterials and related procedures, for example—would facilitate the interoperability
of data, ensuring data quality, consistency and normalization. Examples of major formal standards in
nanotechnology, developed and approved by the main international standards bodies and organizations
(Murashov and Howard 2008, 2011, Hatto 2009, Weidl et al 2010) are listed below, in table 1.
There are many other worldwide initiatives actively involved in the study and development of
nanotechnology standards, such as the International Alliance for NanoEHS Harmonization4, the Nanosciences
African Network5, the Asia Nano Forum6, the Bureau International des Poids et Mesures7, the International
Union of Pure and Applied Chemistry8, the Organisation for Economic Co-operation and Development9 and
the Versailles Project on Advanced Materials and Standards10, among many others.
2.3. Information sources
The variety of nanomedical data sources constitutes another main issue for information management in
nanomedicine. Usually, these sources are disparate and heterogeneous, providing different types of data
in different formats. These sources are also physically separate, forcing researchers to spend research
time locating them. In addition, information sources are of different natures: structured (e.g. databases
and knowledgebases) and unstructured (wikis, technical reports and scientific publications are examples).
Structured sources, where data are well-defined and semantics are implicit, could be easily mined with
automatic methods that are already available for the scientific community: standard queries to databases,
for instance. On the other hand, unstructured sources provide data in free text format, making it difficult to
automate the process of information extraction. Results from nanomedical research are usually reported in
scientific publications and technical reports, resulting in large volumes of unstructured text. As can be seen in
figure 2, the number of publications in the field has grown considerably in the last two decades. This led to
the urgent need to develop advanced natural language processing (NLP) techniques and text mining methods
to convert these unstructured sources to machine-interpretable format. This issue has been partially addressed
in the biomedical domain through biomedical informatics approaches, and should be addressed in the same
way in the nanomedical context, by developing and applying specific nanoinformatics methods and techniques
(de la Iglesia et al 2009).
Although there are several nanomedical data sources, it is necessary to analyze the availability and quality
of such data and properly handle the existing inconsistencies and uncertainties. For instance, protocol details
are inadequately described in research publications and original datasets are rarely provided in manuscripts or
deposited online. Standard methods for data validation should be developed, covering the different aspects of
research conducted in nanomedicine, such as material conditions or protocol parameters. In the last 5 years,
4 www.nanoehsalliance.org/.
5 www.wcpsd.org/posters/environment/Maaza.pdf.
6 http://asia-anf.org/.
7 www.bipm.org/en/home/.
8 www.iupac.org/.
9 www.oecd.org.
10 www.vamas.org/.
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Table 1. Summary of the main current nanotechnology standards.
Terminology/ Measurement/ Materials
nomenclature characterization specifications EHS
ASTM—nanotechnology standardsa
E2490–09 X
E2524–08 X
E2525–08 X
E2526–08 X
E2578–07(2012) X
E2834–12 X
E2859–11 X
E2535–07 X
E2456–06 X
British Standards Institution—nanotechnology British standardsb
PAS 71 X
PAS 130 X
PAS 131 X
PAS 132 X
PAS 133 X
PAS 134 X
PAS 135 X
PAS 136 X
PD 6699-1 X
PD 6699-2 X
PD 6699-3 X
European Committee for Standardization (CEN)—nanotechnologies CEN/TC 352c
CEN ISO/TS 27687:2009 X
EN ISO 10801:2010 X
EN ISO 10808:2010 X
EN ISO 29701:2010 X
Federal Agency for Technical Regulations and Metrology (Russia)d
GOST R 8.628-2007 X
GOST R 8.629-2007 X
GOST R 8.630-2007 X
GOST R 8.631-2007 X
GOST R 8.635-2007 X
GOST R 8.636-2007 X
GOST R 8.644-2008 X
Institute of Electrical and Electronics Engineers—nanotechnology standardse
P1650TM-2005 X
P1690TM X
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Table 1. (Continued.)
Terminology/ Measurement/ Materials
nomenclature characterization specifications EHS
International Electrotechnical Commission—nanotechnology standardization for electrical and
electronic products and systemsf
IEC/TC 113 X X X
ISO—International Organization for Standardizationg
ISO/TC 229 X X X X
ISO/TC 24/SC4 X
ISO/TC 201 X
ISO/TC 202 X
TS Z 0027:2010 X
Occupational Safety and Health Administrationh
1904 X
1910.132 X
1910.133 X
1910.134 X
1910.138 X
1910.141 X
1910.1200 X
1910.1450 X
United Working Group for Nanomaterials Standardization (China)i
GB/T 19619-2004 X
GB/T 13221-2004 X
GB/T 19587-2004 X
GB/T 19588-2004 X
GB/T 19589-2004 X
GB/T 19590-2004 X
GB/T 19591-2004 X
a www.astm.org/Standards/nanotechnology-standards.html#E56.01.
b http://shop.bsigroup.com/en/Browse-by-Subject/Nanotechnology/.
c www.cen.eu/.
d http://rostandart.com/.
e http://grouper.ieee.org/groups/nano/.
f www.iec.ch/.
g www.iso.org/iso/iso catalogue/catalogue tc.htm.
h www.osha.gov/dsg/nanotechnology/nanotech standards.html.
i www.anystandards.com/.
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Figure 2. Number of publications with nano-prefixed terms in the title published over the last 20 years
(1992–2011), following previous studies (Braun et al 1997, Huang et al 2003, Hullman and Meyer
2003, Lee et al 2006). Source: Web of Knowledge (Thomson Reuters)11.
the number of web applications offering access to nanomaterial data sources has grown rapidly, so it has
become necessary to evaluate and compare the specific features of such sources: (i) the scope of the provided
data, (ii) the level of annotation of nanomaterials with relevant information, (iii) the automatic generation of
catalogues from research results and (iv) the use of taxonomies and ontologies to classify the available data on
nanomaterials. Another important feature of nanomaterial inventories to be evaluated, considering its use by
the scientific community, is the search capabilities that it can offer. Searching for nanomaterials by name in
a list sorted alphabetically is an arduous task that does not always generate the desired results. Additionally,
researchers may not always know the name of the nanomaterial they are looking for (only some properties or
the name of manufacturer) and, even when they do know it, it is a good idea to show them other nanomaterials
that have similar characteristics. Using ontologies can assist users who are browsing the entire collection by
organizing the repositories with a hierarchical category classification.
Another relevant characteristic of nanomedical data is its interdisciplinary nature. Data from chemistry,
physics, medicine and other involved fields could be very different in terms of format, measurement units
and vocabulary. Additionally, it generally needs to be integrated with multilevel biological data, ranging from
the population level to the atomic level. The development of comprehensive data repositories linking and
integrating data from diverse domains and different sources—experimental results, scientific literature, clinical
trials, Electronic Health Records, genomics, proteomics, nanomaterials characterization, imaging and disease
information—would lead to the design of more accurate predictive models and simulations of nanomaterials
and their biological effects.
3. Available resources for nanomedical researchers
Several initiatives are currently supporting nanoinformatics research worldwide. For instance, since 2001,
under the National Nanotechnology Initiative (NNI) (Roco 2003), 25 governmental agencies are sustaining
nanotechnology advancements in the United States. Previous initiatives also connect to activities under the
NNI, such as the Global Change Research Program12 and the Networking and Information Technology
11 http://wokinfo.com/.
12 www.globalchange.gov/.
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Table 2. Comparison of some data resources on nanotechnology and type of data provided.
Nanomaterials Technical Scientific Modeling
Resource Database characterization Protocols Assays reports publications Toxicity tools Interactions
Nanomaterials X X X X X X
Registry
NIL X X
ICON Nano-EHS X X X X
database
NBI X X
Knowledgebase
CSN X X X
caNanoLab X X X X
TOXNET X
NanoExPERT X X X X
MICAD X X
NCL X X X X
Research and Development13, as well as other new initiatives, including the Materials Genome Initiative
(National Science and Technology Council 2011), a material innovation infrastructure launched in 2011,
and the Advanced Manufacturing Partnerships. In Europe, diverse projects aim at raising the levels of
nanotechnology knowledge across the European Union Member States by supporting the analysis and
dissemination of results from nanotechnology research, as we will see later in this paper.
The set of available nanoinformatics resources comprises databases, tools and web services useful for
storing, organizing, managing and analyzing the plethora of data generated during nanotechnology research. In
the next sections, we will analyze these resources, providing a comprehensive picture of the ongoing research
efforts and advances in the field of nanoinformatics.
3.1. Data sources
Nowadays, there are several resources providing free access to nanomedical data. These repositories contain
large amounts of heterogeneous information related to nanomedicine, including data about samples and
experiments, specific studies and related protocols, nanoparticle interactions, exposure pathways, delivery
targets, manufacturers, etc. Additionally, many research institutes and groups have developed elaborate
nanoparticle classifications based on different parameters: nanomaterial application domain, size, function,
target and toxicity, among others. The variety of ways used to categorize nanomaterials is the main barrier
to standardizing common classifications. Therefore, the creation of a standard taxonomy for the classification
of nanomaterials is a key element to be considered. The use of standardized data across systems and services
would facilitate the updating and integration of data from many different sources. Below, we provide some
examples of the interesting initiatives that are providing access to sources of information on nanomedicine and
nanomaterials, as well as a comparison of their specific features (table 2).
The Nanomaterial Registry (Ostraat et al 2012) gives access to curated information on the interactions
of nanomaterials with biological and environmental systems, including links to related publications,
modeling tools, computational results and manufacturing guidance. This initiative, created and maintained
by Research Triangle Institute International, is sponsored by the National Institute of Biomedical Imaging and
Bioengineering, the National Institute of Environmental Health Sciences and the NCI. Users can search this
database for information about a specific nanomaterial or compare the properties of multiple nanomaterials.
Users can also browse by nanomaterial type (metals, fullerenes or dendrimers, e.g.), size, shape (one, two
or three dimensions) and surface area. Each record contains information about the physicochemical and
structural characteristics of the nanomaterial, including: size (particle size and distribution), aggregation or
13 www.nitrd.gov/.
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agglomeration state, surface (area, charge, chemistry and reactivity), shape, composition, purity, solubility and
stability. Information about the environmental and biological interactions of the nanomaterial is also provided.
The Nanomaterial Registry is an ongoing project; its first beta version was released to the public at the end
of June 201214 and is updated as new information about nanomaterials is published. This resource will also
offer, in future releases, tools for predictive modeling of nanomaterials. Another relevant data source is the
Nanoparticle Information Library15, an ongoing project for building a web-based nanoparticle repository,
developed by the National Institute for Occupational Safety and Health and the Oregon Nanoscience and
Microtechnologies Institute through the Safer Nanomaterials and Nanomanufacturing Initiative16. A user
can browse nanotechnology reports from a set of 88 nanoparticle records (at the time of writing). Each
record contains the nanoparticle’s material data, such as core element, structure or production method, the
nanoparticle’s image, an abstract describing the chemical and physical properties of the nanoparticle and
information about pertinent scientific publications and other related data, such as its commercial availability or
the sponsoring company or institution. These records also provide links to websites with extended information
about the described nanoparticles. With the same goal, the International Council on Nanotechnology is
developing the ICON Environmental, Health and Safety (EHS) database17. The ICON Nano-EHS database
is a repository of papers related to nanoparticles. At the time of this writing, it contains over 7000 records. In
this repository, the user can perform searches based on a particular characteristic of the nanoparticle—particle
type, exposure pathway, method of study, exposure or hazard target, risk exposure group and production
method—or based on related publications, such as paper type, target audience and content emphasis. This
initiative also provides an analysis tool offering two types of analyses: (i) a simple distribution analysis (pie
chart), which compares categories within a specified time range and, (ii) a time progressive distribution
analysis (histogram), which compares categories over a specified time range and data grouping period.
Another valuable resource is the Nanomaterial-Biological Interactions (NBI) Knowledgebase18, an initiative
funded by Oregon Nanoscience and Microtechnologies Institute (ONAMI) and several US agencies: the
National Science Foundation (NSF), the National Institutes of Health (NIH), the United States Environmental
Protection Agency and the Air Force Research Laboratory. The NBI Knowledgebase is a web-accessible
electronic library that allows users access to precise and standardized data element definitions. It serves
as a repository for annotated data on nanomaterial characterization (e.g. purity, electronic and photonic
properties, size, shape, charge, composition, chemical functionalization and agglomeration state), synthesis
methods and nanomaterial–biological interactions (beneficial, benign or deleterious) defined at multiple levels
of biological organization (e.g. molecular, cellular or organismal), thus providing the framework upon which
to conduct species, route, dose and scenario extrapolations and to identify key data required to predict the
biological interactions of nanomaterials. Computational and data mining tools are currently being developed
and incorporated into the NBI Knowledgebase to facilitate this work.
The comparative analysis of structural complexities in nanoparticles and nanocompounds is a
fundamental factor in understanding the particular properties and behaviors of nanomaterials. Regulatory
approval of new engineered materials should be obtained only after a rigorous review of data from structural
and functional analyses. Thus, the development of accurate models and simulations would be an essential step
for the translation of results from the bench to the bedside, reducing the number of necessary phases required
in clinical trials and, subsequently, the time-to-market of these manufactured nanomaterials. Following this
structural approach, the Collaboratory for Structural Nanobiology (CSN)19 initiative, coordinated by one of
the co-authors, provides a database of chemical and structural models of nanoparticles such as dendrimers,
buckyballs, nanotubes and metallic particles. Each nanoparticle is associated with its correspondent structure
file, similar to those offered by the Protein Data Bank (PDB), and related research data, such as molecular
weight, simplified molecular input line entry specification or studies on van der Waals forces. The platform
14 www.nanomaterialregistry.org.
15 http://nanoparticlelibrary.net/index.asp.
16 www.greennano.org.
17 http://icon.rice.edu/report.cfm.
18 http://nbi.oregonstate.edu/.
19 http://nanobiology.ncifcrf.gov.
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Figure 3. Example of nanoparticle record in the CSN: a 3D representation of a fullerene (DF1-mini).
Figure 4. Sample panel of a video simulating the water molecular dynamics of DF1-mini in the CSN.
also provides several tools for the two-dimensional and three-dimensional (3D) visualization of nanoparticles
(figure 3), as well as representative videos of dynamic simulations of such nanoparticles (figure 4). This kind
of approach could lead to future platforms upon which to share structural and predictive models.
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Another interesting data source for nanomedicine is caNanoLab20, a portal for sharing information
about nanomaterial characterizations resulting from cancer-related nanotechnology research, funded by the
NCI. It supports the annotation of nanomaterials with data from in vitro assays and allows linking to
remote characterization protocols. At the time of writing, the caNanoLab Portal (v1.5.3) provides access
to 41 protocols and 886 samples from different sources, supplying information about the sample, such as
composition, function and characterizations and providing access to more than 1000 publications related to
the stored samples. In addition, the portal supplies the data submission date in the search results. It is an
open-source initiative, so users are able to download the source code21 and try it in their own systems.
Also accessible through the web, the Toxicology Data Network (TOXNET)22 provides access to
toxicology data for about 5000 chemicals, including nanomaterials. TOXNET comprises several databases
from the US National Library of Medicine and some of them—the Hazardous Substances Data Bank (HSDB)
and TOXLINE—allow general and specific searches about nanoparticles and nanostructures. Records can
be queried by substance name or Chemical Abstract Service number. The HSDB provides chemical records
about nanotoxicity by means of descriptions of physicochemical properties, toxicity studies, pharmacology,
manufacturing, environmental and health safety, pharmacodynamics, etc. On the other hand, TOXLINE
provides bibliographic records of scientific papers related to nanomaterials’ toxicity. All of this information
is presented to the user in free text, but can also be integrated with other applications via its web
services Application Program Interface. NanoExPERT23, the Nanomaterials Experiment-based Predictor of
Environmental Risk and Toxicity, is another tool that provides fate and toxicity predictions for nanoparticles,
as well as a database containing experimental results from peer-reviewed journals. With respect to images
databases, the Molecular Imaging and Contrast Agent Database24, developed by the National Center for
Biotechnology Information (NCBI) at the NIH, stores imaging data about a range of nanomaterials, such
as nanobubbles, quantum dots and gold nanoparticles.
Finally, it is worth mentioning the Nanotechnology Characterization Laboratory (NCL)25 for conducting
preclinical studies to characterize nanomaterials that are used for in vivo diagnostics and therapy against cancer.
This outstanding nanotechnology institution, developed through a collaboration between the NCI, the FDA
and the National Institute of Standards and Technology, provides access to a set of high-quality technical
reports regarding liposomes, fullerenes and dendrimers. There are also other available databases dedicated to
collecting transversal data about nanotechnology, such as the database of nanoscience journal publications
developed by Braun (Braun et al 1997) and the database of nanotechnology patents, developed by Meyer
(2000, 2001).
3.2. Standards, terminologies, taxonomies and ontologies
In order to address the organization and homogenization of the huge volume of information that
nanotechnology research is producing nowadays, scientists need support from lexical and semantic tools,
such as terminologies, vocabularies, nomenclatures, code and synonyms sets, lexicons, thesauri, ontologies,
taxonomies and classifications. Specifically, there is an urgent demand for guidance in labeling and annotation
of nanomaterials, as well as for the production of electronic tools for standards development and revision.
Besides, since ontologies are meeting urgent needs in other areas, such as biomedicine (Maojo et al 2011),
it is reasonable to think about their applications in the nanomedical field. Ontology is a model describing
the concepts of a specific domain, as well as their categories and relations. In nanoinformatics, ontologies
can be considered a semantic framework representing the nanotechnology domain. This model may contain a
myriad of chemical, physical and nanotechnology concepts that can be used as controlled terminology for data
management and analysis, allowing further nanoinformatics tasks, such as the annotation of experimental data
20 https://cananolab.nci.nih.gov/caNanoLab/.
21 http://ncicb.nci.nih.gov/download/downloadcalab.jsp.
22 http://toxnet.nlm.nih.gov/.
23 https://nanoexpert.usace.army.mil.
24 www.ncbi.nlm.nih.gov/books/NBK5330/.
25 http://ncl.cancer.gov/.
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or the integration of heterogeneous data sources, to be undertaken. Considering the extensive vocabulary and
the wide range of names and terms for the same concepts in this area, ontologies would provide a mechanism
to standardize the representation of the nanomedical domain that could be very useful for the dissemination of
information and knowledge that exists in this field in a machine-readable format and to express the metadata
related to nanomaterials in a semantically interoperable way.
In 1999, Freitas proposed a primer vocabulary for nanomedicine in the Nanomedicine Book Glossary
(Freitas 1999), included in his nanomedicine book series26, followed by a partial taxonomy of nanomedical
technologies, published in 2005 (Freitas 2005). That same year, Tanaka developed a preliminary ontology for
nanoscience, a meta-level ontology for nanoscale research (Tanaka 2005), based on an analysis of the subject
headings and controlled index terms of papers published in journals related to materials science, physics,
chemistry, engineering, medicine and biology.
Some popular indexes, such as the Library of Congress Classification27, the Dewey Decimal
Classification28 and the Bliss Bibliographic Classification (Thomas 1997) are already indexing nanoscience.
There also are biomedical and material science indexes that include nanotechnology, such as Medical
Subject Headings, a controlled vocabulary for indexing publications (Lowe and Barnett 1994), and the
NCI Thesaurus (Sioutos et al 2007)29, developed by the NCI Center for Bioinformatics as part of
the Enterprise Vocabulary Services Project, among others. Additionally, standardized terminologies for
nanotechnology and nanosciences can be accessed through the websites of the main international organizations
for standards, as noted in previous sections of this review, e.g. the Standard Terminology Relating to
Nanotechnology included in American Society for Testing and Materials (ASTM) E2456–0630 (published
by ASTM International, formerly known as the American Society for Testing and Materials). Other non-
standardized glossaries and vocabularies, developed by research institutions and companies, can be found
on the web, such as the Glossary for NanoBiotechnology31, developed by JPK Instruments, and the
Glossary of Nanotechnology Terms32, created by the UK Institute of Nanotechnology. The Dictionary
of Nanotechnology33 expands such glossaries with single-level classification, offering a nanotechnology
vocabulary that contains terms collected from different scientific sites and references and classified into
different categories: general, nanomaterial and nanoelectronic, nanomedical, nanobio and bionano, carbon
nanostructure, nanocharacterization, nanofabrication and molecular nanotech.
Several general taxonomies for nanotechnology can also be found on the Internet. For instance, the
Nanotechnology Taxonomy developed by Codesta34, which divides nanotechnology products based on their
manufacturing process by using three criteria: manufactured state, chemistry of fabrication and means of
arrangement, and the Nanomedicine Taxonomy developed by the Canadian NanoBusiness Alliance35, which
classifies terms by their area of application (e.g. biopharmaceuticals, implantable devices, surgical aids, and so
on). Another example is the taxonomy developed by Wong et al (2007) for classifying patents based on their
area of application: (i) instrumentation, (ii) chemical processes and materials, (iii) medical and biotechnology
and (iv) nanoelectronics. In a similar direction, the United States Patent and Trademark Office included in its
classification a hierarchical terminology named Class 977 ‘Nanotechnology’36 to categorize existing patents
in the field. Nanosafe Inc.37 also provides a logical classification of nanoparticles based on their elemental
composition, properties and toxicity in support of defense-related nanotechnology applications.
26 www.nanomedicine.com/.
27 www.loc.gov/aba/cataloging/classification/.
28 www.oclc.org/dewey/resources/summaries.en.html.
29 http://ncit.nci.nih.gov/ncitbrowser/pages/home.jsf?version=12.05d.
30 www.astm.org/Standards/E2456.htm.
31 www.jpk.com/glossary/index.htm.
32 www.nano.org.uk/nano/glossary.
33 www.nanodic.com/.
34 http://nanotech2k3.bravepages.com/.
35 www.pain.cz/nanomedicina/files/taxanomy.pdf.
36 www.uspto.gov/web/patents/classification/uspc977/defs977.htm.
37 www.nanosafeinc.com/.
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The InterNano initiative, a project of the National Nanomanufacturing Network funded by the NSF, is
developing a general taxonomy38 that defines the nanotechnology domain. The InterNano taxonomy brings
together content about nanomanufacturing from a variety of sources and is divided in eight main categories,
titled: (i) Areas of application, (ii) Environment, health and safety, (iii) Informatics and standards, (iv)
Nanomanufacturing characterization techniques, (v) Nanomanufacturing processes, (vi) Nanoscale objects
and nanostructured materials, (vii) Social and economic impact and (viii) Tool development. Many of these
categories, in turn, are divided into several subcategories down to three levels of granularity. The taxonomy
can be navigated in three different ways: as a hierarchical tree, as a tag cloud or as graph with nodes,
presenting the relationships between the extant terms of the taxonomy. The database contains over 1000
elements and each element of the taxonomy is tagged and linked to the portal’s contents and repositories,
which include descriptions, scientific publications, technical reports, techniques, methodologies and patent
information related to manufacturing processes for nanostructured materials and devices. It also includes
lists of organizations and contributors to these processes, as well as usage statistics. Users can submit their
own processes by uploading the related information in standard forms, facilitating the dissemination of this
knowledge to organizations and laboratories.
The NanoParticle Ontology (NPO)39, primarily developed by Thomas et al (2011) and currently
supported by the NCI’s cancer Biomedical Informatics Grid (caBIG R©) Nanotechnology Working Group
(Nano WG), provides the frame of reference for representing the cancer nanotechnology domain. A user
can organize and annotate knowledge underlying the preparation, chemical composition and characterization
of nanomaterials involved in cancer research by browsing and navigating the ontology’s hierarchies of
classes. Currently, NPO researchers are focused on support for ISA-TAB-Nano40, an extension of the
standard investigation/study/assay (ISA) format41 developed by the European Bioinformatics Institute, and
other annotation projects. The NPO is also being updated to include a broader range of nanotechnology
concepts. The continuous advancements in the development of this ontology translate to great steps forward
for nanotechnology standardization and data interoperability, paving the way toward a global ontology for
nanomedicine.
Despite of the myriad varieties of glossaries, vocabularies and taxonomies focused on nanotechnology,
there is an urgent need for a unique controlled vocabulary for the nano domain and, specifically, a standard
specification, to facilitate the import/export of data on nanomaterials and their characterizations to/from
nanotechnology resources. A current major effort to reach consensus in nomenclature and categorization is
ISA-TAB-Nano, a standard, approved by ASTM International, which aims to represent and share information,
including characterization data, about nanomaterials. Developed by the NCI’s caBIG R© Nano WG, this standard
provides a framework for describing investigations, studies, materials and assays through plain text files.
In addition, ISA-TAB-Nano supports nanomaterials and concepts from the NPO, facilitating annotation and
integration with this ontology.
3.3. Modeling and simulation tools
Creating in silico models and simulation environments at the nanoscale could assist in the prediction and
assessment of risks of engineered nanomaterials; for instance, modeling differences in toxicity response due
to changes in particle properties. In this respect, it would be necessary to determine which characteristics are
most important for building a high-quality model, and to include these characteristics in accurate modeling
and simulation tools. It would also be fundamental to abandon the current theoretical approach and consider
factors such as the dependences between the nanoparticle’s properties and the system where they are embedded
or the behavior and time-scale of nanoparticles in the human body (degradation, toxicity, side effects, etc). For
this purpose, extended knowledge about the biological identity of engineered nanomaterials (function, related
38 www.internano.org/component/option,com internanotaxonomy/.
39 www.nano-ontology.org/.
40 https://wiki.nci.nih.gov/display/ICR/ISA-TAB-Nano.
41 http://isa-tools.org/.
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biological effects, domain of application, relationships between particle shapes and toxicity, etc) would be a
requisite (Lynch et al 2009).
Also to be developed are modeling and simulation tools that would allow researchers to
predict new properties and potential structures to acquire knowledge about the nature and behavior
of nanoparticles. These data could include: (i) nanomanufacturing models for the virtual design of
engineered nanomaterials considering various requirements simultaneously: nanomaterial physicochemical
characterization, functionalization of the nanomaterial surface and design and control of synthesis processes,
among others; (ii) models of pharmacokinetics and pharmacodynamics; (iii) models of nanoparticles’ life
cycle in the body: biodistribution, metabolism disposal, immunogenicity, clearance, phagocytosis, etc; and
(iv) quantitative structure–activity relationships (QSARs) for modeling nanoparticle structure, nanotoxicity
and nanoparticle interactions in biological environments at the tissue, cellular, molecular and atomic level.
A good example is the work carried out at the UCLA Center for the Environmental Implications of
Nanomaterials (CEIN). CEIN researchers have developed nano-QSARs (Puzyn et al 2011) for predicting
nanoparticle toxicity (Liu et al 2013) as well as a set of web-based high-throughput data analysis tools for
rapid analysis of nanotoxicity data42.
3.4. Educational tools
Due to the novel and heterogeneous character of nanoinformatics, the development of interdisciplinary
and cross-disciplinary education programs integrating nanomedicine, biology, materials science, physics,
chemistry and informatics has become a priority (Greenberg 2009). Over the last few years, several educational
resources and repositories have emerged to give training support to researchers working in the field.
For instance, nanoHUB43 (Qiao et al 2006) is a web portal for educational purposes developed by
the Network for Computational Nanotechnology and sponsored by NSF under the NNI. This modeling
and simulation framework offers real-time demonstrations of a myriad of extant computational resources in
nanotechnology, materials science, physics and chemistry. NanoHUB does not allow the direct upload of
experimental data, but users can run specific simulations and models by selecting the values for the different
parameters requested by each resource. Users can also act as contributors, uploading their own resources and
making them accessible to the vast scientific community supported by nanoHUB. Additionally, the portal
provides access to courses and learning material—such as extensive lecture notes, quizzes, exams, homework
and exercises—video lectures, animations, presentations about the available resources, online seminars, related
scientific publications and information about events and job opportunities. There are also question-and-answer
forums for interacting with professors and other students. Similar educational frameworks for e-learning on
nanotechnology (e.g. Nano4Me44) are gaining force in the web.
The NCL is also conducting educational activities by publishing and publicly disseminating the recent
advances in preclinical studies on nanomaterials by means of scientific bibliographies and conferences, news,
open forums and press notes in scientific media. There are also plenty of web pages and other media oriented
to the general public that serve to distribute this information. For instance, Nanowerk45 and NanoTechWeb46
provide access to nanotechnology articles and news oriented to scientists and to the general public.
In spite of the didactic initiatives mentioned above, it is still necessary to develop and sustain additional
educational resources and an international network of skilled professionals, as well as the supporting
infrastructure and tools to advance training in nanotechnology. This involves the organization of workshops at
international scientific events that engage students, technicians and trainees in nanotechnology environmental,
health and safety considerations, and the establishment of a network of websites for student recruitment and
dissemination of information, e.g. webinars and courses.
42 http://nanoinfo.cein.ucla.edu/public/hdat/default.aspx.
43 http://nanohub.org/.
44 http://nano4me.org/webinars.php#showW5.
45 www.nanowerk.com/.
46 http://nanotechweb.org/.
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3.5. Working groups on nanoinformatics
In order to integrate and disseminate information on global nanotechnology research efforts, it is necessary
to create and sustain international groups of interest by identifying experts in the field among networks,
research organizations, public agencies and the nanotechnology industry. Working groups provide an
excellent opportunity to bring together individuals representing a broad range of perspectives to accomplish
a common goal. While scientific communities in long-established areas, such as bioinformatics, have
demonstrated the high value of collaborative approaches to advance science, such efforts by the newer
nanoinformatics community are less developed. However, this is changing quickly through the organization
of joint workshops and publications, as well as the creation of working groups within in various sub-
areas under development. These working groups are composed of scientists from different laboratories,
research institutions and universities, committed to working together and sharing complementary capabilities
to enhance nanotechnology research.
For instance, the caBIG R© Nano WG47 is developing concerted activities and several pilot projects48.
Decisions and processes within the group are consensus-driven and representatives from the participant groups
meet regularly, generally once a week. Within this set of pilots, it is worthwhile to highlight the Meta-
ontology Pilot49, related to the NPO, and the ISA-TAB-Nano pilot50, related to the standard previously
described in this paper. In Europe, there are multiple collaborative initiatives, such as QNano51, a research
infrastructure for nanomaterial safety and quality testing; NanoImpact.net52, a network concentrating on
the health and environmental impact of nanomaterials; the EU NanoSafety cluster53, a group of European
Commission-funded projects working on nanotoxicology and nanosafety issues and involved in the preparation
of new research topics for the next European-funded Framework Programme (Horizon 202054); the European
Technology Platform on Nanomedicine55, a group of industrial and academic stakeholders working for
the establishment of a shared vision an research lines in the area; the European Technology Platform for
Micro- and NanoManufacturing56, a collaborative platform for discussing topics of interest to industrial
micro- and nanomanufacturing; MODENA57, an action modeling nanomaterial toxicity; and NANOfutures58,
a shared environment for collaboration between industry, academy and society on nanotechnology issues
which is currently creating a roadmap in the area, among many others. These European groups are working
cooperatively to achieve their individual scientific goals, as well as to meet the common objective to advance
nanotechnology research at the European level. In the international context, it is particularly worthwhile
to mention the ongoing work of the US-EU dialogue, ‘bridging nanoEHS research’59, which is supporting
nanotechnology through the establishment of worldwide Communities of Research.
4. Cyberinfrastructures for nanomedical data management: current limitations and future prospects
The existing nanotechnology platforms, data resources and tools are powerful, but some aspects are already
being improved. For instance, usually each service provider’s interface is different—both in the subset of
data presented and in structure—and each institution promotes its own web sites, services and data formats.
This presents a challenge to nanomedical researchers, who typically need to link data from multiple online
47 https://wiki.nci.nih.gov/display/ICR/Nanotechnology+Working+Group.
48 https://wiki.nci.nih.gov/display/ICR/Pilots.
49 https://wiki.nci.nih.gov/display/ICR/Meta-Ontology+Pilot.
50 https://wiki.nci.nih.gov/display/ICR/ISA-TAB-Nano#ISA-TAB-Nano-Scope%3A.
51 www.qnano-ri.eu/.
52 www.nanoimpactnet.eu/.
53 www.nanosafetycluster.eu/.
54 http://ec.europa.eu/research/horizon2020/.
55 http://cordis.europa.eu/nanotechnology/nanomedicine.htm.
56 www.minamwebportal.eu/index.php?m1=Public-Area.
57 www.cost.eu/domains actions/mpns/Actions/TD1204.
58 www.nanofutures.eu/.
59 http://us-eu.org/.
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sources to generate a data set for further analysis. The development of new standards and specifications, like
the ISA-TAB-Nano and the NPO, is directed at harmonizing access to nanotechnology data.
Another issue is that the development of inventories of nanomaterials has been done without automating
the process, thus consuming a big part of researchers’ time. Inventories are manually maintained by trained
personnel who conduct periodic updates based on the new published material on nanoparticles. In fact, some
of these data sources are not pure databases, but web pages containing lists of nanomaterial descriptions. In
some cases, users can contribute by uploading new data. Nevertheless, now that relevant resources are widely
distributed over the web and data are made available in different formats, manual integration has become
almost infeasible and could lead to the publication of non-comprehensive indexes that include only a portion
of the available data about nanomaterials. To replace the manual development of nanomaterials repositories,
there are some quite innovative approaches that could generate indexes of nanomaterials in an automatic
manner. These approaches would facilitate the initial implementation of the index and, above all, allow its
continuous update and curation, adding new information and deleting the obsolete data. Due to the rapid
growth of information about new experiments and results in nanomedicine, the automation of the creation and
update process is an important element to be considered.
Joining data sources together is quite problematic, as they frequently have insufficient or non-existent
metadata describing the nanomaterials. An important consequence of the lack of metadata is that some existent
nanomaterials cannot be found in all the registries. Besides, sometimes the information provided by the
different sources is not directly compatible with other sources and tools. These issues are being addressed
by applying information technology methods and techniques and, therefore, a comprehensive infrastructure
is needed to support an interoperable network of data and analytical services. Transforming the current
efforts to develop databases and tools for nanomedical research into a dedicated nanoinformatics research
infrastructure requires an understanding of the needs of the scientific community, the need for efficient and
high-quality management of information at the nano level and an understanding of the strengths and weakness
of experimental results and clinical data. This multidisciplinary, open and free infrastructure should provide
a new way for scientists to immediately access and use data from nanomedical research, saving them from
investing time in fruitless web searches. With such an infrastructure, researchers can focus on moving forward
with their research, not on acquiring the necessary resources for data analysis and management.
For instance, in the United States, the NNI60 has led to public funding for nanotechnology research
(see figure 5). According to a recent NNI statement61, published on 14 May 2012, the establishment
of a Nanotechnology Knowledge Infrastructure is a priority research line for the forthcoming years.
The Subcommittee on Nanoscale Science, Engineering and Technology, within the National Science and
Technology Council’s Committee on Technology, announced, through the publication of a White Paper62,
the fourth Nanotechnology Signature Initiative to stimulate the development of and improvements in the tools
and methods required to access, organize and gather breakthroughs from huge amounts of data generated by
nanotechnology, beginning to weigh in on just what data really need to be intelligently managed and stored.
4.1. Previous successes in the biomedical domain
Computational resources and infrastructures for biomedicine have successfully given support to address a
major part of the challenges existing in the field of biomedicine. For instance, the development of databases,
tools and services has accelerated advancements and findings in the omics fields. Researchers have benefited
from these resources, adapting their professional skills to the new technological requirements for managing
biomedical information. This has been the case for numerous existing omics databases that have proliferated
in recent years, providing a common framework for research on genomics (e.g. Online Mendelian Inheritance
in Man (Hamosh et al 2005), Ensembl GenBank (Benson et al 2012) and Artemis (Rutherford et al 2000));
proteomics (e.g. PRoteomics IDEntifications Database (Martens et al 2005), Database of Interacting Proteins
60 www.nano.gov/.
61 www.nano.gov/node/819.
62 www.nano.gov/sites/default/files/nki nsi white paper - may 14 2012 secured.pdf.
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Figure 5. Comparison of the NNI investment distribution (2011–2013) into the different nano areas
between two US governmental agencies: the NSF (covering general research on nanotechnology) and
the NIH (focused on nanomedicine). Source: NNI Dashboard63.
(Xenarios et al 2002), Swiss–Prot (Bairoch and Apweiler 2000) and Universal Protein Resource (Bairoch et al
2005)); epigenomics (e.g. NCBI Epigenomics); metabolomics (e.g. Human Metabolome Database (Wishart
et al 2007)); and others.
An exemplary model to emulate would be the development strategy for the PDB (Berman et al 2000), the
outstanding, worldwide protein structure database. The PDB has grown over the decades, since its creation in
1971, as a result of international collaboration between researchers who have deposited their protein structures
in the database. This open strategy—where researchers can submit their own work, following a set of standards
and guidelines, and research institutions act as storage, data processing and distribution centers for PDB data
(Berman et al 2003)—led to the cooperative development, population and curation of this database.
In biomedicine, several application development projects have emerged for constructing and managing
computational pipelines from existing bioinformatics databases and tools. A good example is iTools64
(Dinov et al 2008), a system for classification, categorization and integration of different computational
biology resources. This system has several functionalities, such as storage, searching, traversal and retrieval
of resources and their corresponding metadata description. iTools infrastructure includes an ontology of
computational biology resources, a database of descriptions of computational biology resources and an
infrastructure for integration and interoperability of meta-algorithms for biomedical computing. Each resource
is annotated with metadata that includes a short description, its authors, version, date and stage, the ontology
classification of the resource, a set of keywords and the implementation language. In the ontologies’ area, it
is worthwhile to mention the BioPortal (Noy et al 2009), a compendium of ontologies for life sciences that
is constantly updated with new ontologies and new versions of the existent ones. Regarding the indexing of
bioinformatics databases and tools, there are some remarkable ontologies attempting to generate a standardized
classification of bioinformatics resources, like the Biomedical Resource Ontology65 (Musen et al 2008),
a controlled terminology defining bioinformatics resources types under development by NIH researchers
who have an interest in the classification of such resources. Medical imaging is another field that has
grown considerably due to successful advances in the techniques for image acquisition, analysis, storage and
63 http://nanodashboard.nano.gov/.
64 http://itools.loni.ucla.edu/.
65 http://bioportal.bioontology.org/.
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Figure 6. The NanoPortal: A hypothetical, multidisciplinary, open infrastructure enabling uniform
access to a myriad of resources on nanotechnology.
annotation. A renowned resource in this field that should be mentioned is Digital Imaging and Communications
In Medicine (DICOM)66, the standard for exchanging medical images.
All of these resources are highly accessed by biomedical researchers on a daily basis, which indicates the
relevant role for computational tools and infrastructures in conducting and reporting experimental research.
While it is certainly correct that investigators typically do not control the systems in the sense of design,
administration, etc, they do maintain the data. Thus, these sorts of approaches should be followed in the
nanomedical area to develop and publish nanoinformatics resources.
4.2. Requirements for developing a nanoinformatics infrastructure
This section describes the desired elements of a hypothetical, multidisciplinary, open infrastructure, a research
framework including a set of applications enabling easy access to a myriad of nanomaterials, enhancing
cooperation among different institutions and researchers (see figure 6). This infrastructure should provide
users with uniform access to a wide set of sources of nanomaterial data, not only collecting and integrating
information from different databases but also offering information (metadata) about the source of the data. The
nanoportal should offer services for sharing data and resources between researchers—e.g. scientific articles,
demos, access to nanomedicine databases, ontologies, terminologies. It would also serve as dissemination
channel for characterization data and aim at looking across characterization profiles and techniques. In order
to accelerate the discussion and validation of nanomedicine research data, the infrastructure should support
services for data annotation, data curation and data quality rating, which could improve the quality of published
experimental results. Curation will rely on the literature descriptions as well as in registered experiments
and results. The infrastructure should also help researchers to keep track of their experiments (techniques,
parameters, protocols details) and then apply computational techniques and methods to analyze and inference
knowledge from such data. We believe that such an open-environment approach could foster the development
66 http://dabsoft.ch/dicom/index.html.
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Figure 7. Schematic representation of the main components of the infrastructure and their
interconnections.
of novel integrative tools, accessible over the Internet, to share nanotechnology knowledge and resources
through a geographically distributed virtual community.
This infrastructure could be divided into two different parts (figure 7). The first one would consist of
a Data Repository to support the exchange of nano research data, publish data generated by the research
community and make these data freely available. All these data would be stored in a database to be queried over
the Internet. Each nanomaterial would appear annotated with its corresponding information and the whole data
set would be wrapped by an upper-level ontology. The second part would be the Tool Repository containing
tools and services which would be classified into several categories: acquisition, calibration and quality
assurance; data upload, storage and management; analysis and processing; data sharing and collaboration;
visualization and ‘atlasing’ tools; and standards, terminologies and ontologies. For this purpose, the automatic
assignment of categories to the nanomaterials could be carried out with the use of text mining and NLP
techniques to extract relevant information from papers describing them. Clustering engines could also help in
this categorization by the application of standard mechanisms and algorithms, such as normalization, feature
selection, consensus clustering and multidimensional scaling, among others (Garcı´a-Remesal et al 2010).
Nanomaterials would be clustered into sets so as to discover useful patterns (Garcı´a-Remesal et al 2013).
Data and tools gathered in the repositories should be committed to an open-source policy and the software
should be freely available, allowing users to share their tools.
The creation of such a nanoinformatics platform would also involve the mandatory development of the
following elements:
• Terminologies, thesauri and vocabularies defining the nanotechnology domain and, specifically, the
nanomedical semantic context: the proposed data model would use nanomedical domain information
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captured in terminologies, thesauri and taxonomies, which provide information related to nanomaterials,
such as chemical descriptors, toxicity, size and structure. The organized description of nanomaterials
through these properties will enable users to make advanced searches, such as all nanomaterials that
perform a specific function or have a concrete composition.
• Standards that will allow data and systems interoperability: having a controlled terminology is a key
factor for indexing and integrating nano sources; therefore, the platform should be supported by a set of
well-established international standards.
• Taxonomies and ontologies modeling the scientific knowledge existent in the nanomedical domain,
including the design and implementation of services for searching and managing such taxonomies and
ontologies: for organizational purposes, the ontology could be separated into two different components:
the domain ontology, an annotation vocabulary that would include descriptions of nanomaterial data types
and their relationships, and the service ontology, which would describe the operational features of services
within the domain ontology. The final goal of this ontology would be to capture the semantics of the
relationship between the different nanomaterials, providing a contextual framework to share data and
develop interoperable resources using this information.
• Databases of related resources, bibliography, data sources, etc., including services for generating use
statistics and monitoring user preferences: as the nanotechnology field grows, it has become harder
to find and access all the knowledge that is relevant to the discipline. In addition, non-specific search
engines—such as Google—produce too general and massive results, so, in most cases, researchers are
unable to find the best resource to obtain the target information necessary for their research. Therefore,
it is necessary to solve the gap between the rising information needs of nanomedical researchers and
the growing number of information sources available through the web, and create inventories indexing,
describing and linking the existing data. As we have seen before, over the last years, several research
groups and laboratories have developed directories of resources which work as ‘yellow pages’ for the
biomedical scientific community. The same approach should be followed by the nanomedical community,
promoting the dissemination and sharing of the currently available resources in the field. Then, it would
be needed to describe potential applications of these indexes, including the automatic orchestration
of nanoinformatics workflows, or novel methods to integrate public-online nanomedical databases and
tools.
• Tools for the analysis and visualization of experimental results, accompanied by reference data sets for
testing new algorithms.
• Tools for nanotechnology-oriented simulation and modeling.
• Communication services between users, including the development of tools for knowledge and resources
exchange among researchers working in the area: This brokerage system would allow users to register
their own nanomaterials and tools and provide an inventory for use by others in acquiring the desired
data by means of a syntactically and semantically matching process, by entering words or phrases. This
is a flexible novel paradigm already applied in biomedicine, which successfully integrates knowledge
obtained from databases using Semantic Web technologies, sharing a common ontology and that can be
accessed through normalized URLs.
• Documentation repositories providing researchers with intelligent search tools, as well as services for
version control.
• Resources and tools for management of recent contents, alerts and news published in the area.
• Learning tools and consultation forums.
Finally, this hypothetical cyber-infrastructure should also support different views for different type of users, for
instance: (i) small data users versus massive data users; (ii) novice users versus expert users; (iii) researcher’s
view versus patient’s view versus administration’s view versus clinician’s view; and (iv) basic research versus
translational research.
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5. Conclusions
As discussed above, nanomedical research is producing huge volumes of information due to the numerous
advances in the nanotechnology field. Due to the fact that the nature of this information is heterogeneous
and has different levels of granularity, researches are facing many challenges in analyzing all these data.
Consequently, the use of computational methods for the design and development of innovative analysis
tools has progressively gained higher relevance, requiring new publicly accessible resources that facilitate
the cooperative work between research groups working in the field.
In this paper, we have analyzed the urgent need to use automatic approaches to efficiently manage the
new data generated during nanomedical research. This knowledge must be organized and structured, by means
of the creation of standard domain models, and annotated by labeling data using existing terminologies,
vocabularies and ontologies. The constant publication of new results in the area also demands a continuous
update of data resources, which cannot be done manually, thus resources providing new methods for
automatically updating these resources are crucial.
One of the main challenges in nanoinformatics is the variety and heterogeneity of the nanomedical
domain, where users have very different needs, depending on their training and professional role. In order
to understand the current problems and challenges and to develop the required applications to address them,
nanoinformatics researchers should have a fluid communication with the scientific community conducting
research in the area. This research involves professionals with varied profiles working in very different areas:
chemistry, physics, medicine, the pharmaceutical industry, among others (including the materials science and
engineering community), working closely with technology developers and manufacturers. It is necessary
to consider social factors, as well, since they affect the acceptance of nanomedicine by consumers and
its impact upon them in a global way. With this in mind, a great effort should go into undertaking and
analyzing nanotoxicity studies, taking into account the results of previous studies, and the results, both positive
and negative, managed as a complete information set and made easily available. Computational methods
for modeling and simulation in nanomedicine are vital for understanding the behavior and interactions of
engineered nanoparticles, as well as their biological effects within the human body and the environment.
Finally, due to the large number of new nanomaterials that are being produced by manufacturing
processes, an open approach is necessary with regards to the publication of new research data. A major
portion of the information about nanoparticles studies, assays and clinical trials can be found in the scientific
literature, but there is a lack of publicly available databases and repositories of structured information. In
order to accelerate advancements and improvements in nanomedicine and nanoinformatics, easy availability of
experimental and clinical data is essential, allowing for inference of information from data and the subsequent
integration of research results. Thereby, current informatics methods and techniques for text mining and NLP
can help to characterize and classify nanomaterials, as well as identify data correlations from current research
results.
By adopting such a big-picture approach, we can foster a community of integrated and coordinated
research groups, facilitating the creation and support of interdisciplinary teams. Scientific groups collaborating
through a nano-platform or cyber-infrastructure should include basic and translational scientists, clinical
researchers and computer scientists. This kind of platform would also promote the establishment of
public–private partnerships across the different areas involved, leading to long-term sustainability of funded
research programs. The definitive establishment of nanotechnology in medicine and industry depends on all
of these factors where, as we have seen, nanoinformatics is critical to improving the attainment of research
results.
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